An Observational, Prospective, Open Label, Multicenter Study to Evaluate the Safety and Effectiveness of Pegfilgrastim As Secondary Prophylaxis to Decrease the Incidence of Febrile Neutropenia in Korean Female Patients with Breast Cancer